Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (9)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2017

  1. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))

    Nature Genetics

2014

  1. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Nature Genetics, Vol. 46, Núm. 7, pp. 736-741

2001

  1. Low doses of Epo activate MAP Kinases but not JAK2 - STAT5 in rat vascular smooth muscle cells

    Biochemical and Biophysical Research Communications, Vol. 284, Núm. 4, pp. 1031-1038

  2. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

    Endocrinology, Vol. 142, Núm. 9, pp. 3950-3963

2000

  1. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

    Oncogene, Vol. 19, Núm. 41, pp. 4695-4705

  2. Involvement of prolactin in breast cancer: Redefining the molecular targets

    Experimental Gerontology, Vol. 35, Núm. 1, pp. 41-51

1998

  1. Mental health expectancy: An indicator to bridge the gap between clinical and public health perspectives of population mental health

    Acta Psychiatrica Scandinavica, Vol. 98, Núm. 3, pp. 182-186

1993

  1. Preservation of antigenic reactivity after cryofixation, cryosubstitution, and cryoembedding in Lowicryl HM23: Application to alcohol dehydrogenase in Drosophila fat body

    Microscopy Research and Technique, Vol. 24, Núm. 5, pp. 453-454